New treatment option for Bladder Hyperactivity
Official title Evaluation of Autonomic Nervous System Changes in Response to Stimulation by Sacral Neuromodulation
ClinicalTrials.gov ID: NCT06434831
What this study is testing
- What it's testing
- Overactive bladder syndrome (OAB) is defined by urgent and frequent urges to urinate associated with frequent night-time urination and sometimes urinary incontinence. Sacral neuromodulation (SNM) is now one of the second-line treatments for OAB.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Male of female ≥ 18 years
- OAB syndrome
- Indication for a two-staged SNM
- Under general anaesthesia with Remifentanil and Propofol
- Patient who has given written consent to participate in the trial
You likely can't join if
- Tibial neuro-stimulation (last 3 months)
- Sacral neuromodulation (last 3 months)
- Botulinum toxin A intra-detrusor injection (last 9 months)
- Pregnancy in progress
- Administrative reasons
- Guardianship/curatorship
See the full eligibility criteria
- Male of female ≥ 18 years
- OAB syndrome
- Indication for a two-staged SNM
- Under general anaesthesia with Remifentanil and Propofol
- Patient who has given written consent to participate in the trial
- Patient willing to comply with all study procedures and duration
- Tibial neuro-stimulation (last 3 months)
- Sacral neuromodulation (last 3 months)
- Botulinum toxin A intra-detrusor injection (last 9 months)
- Pregnancy in progress
- Administrative reasons
- Guardianship/curatorship
The study team makes the final eligibility decision.
Where it's taking place
- Lille, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lille, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.